ArriVent BioPharma Stock (NASDAQ:AVBP), Quotes and News Summary

Q: What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ArriVent BioPharma Stock (NASDAQ: AVBP) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 171.059K
Day Range	- - -
52 Wk Range	14.350 - 25.950
Market Cap	$674.899M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	6.66%
Days to Cover	10.42

Recent News

ProfoundBio Discovers The Joys Of Having A Wealthy Owner

Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months By Doug Young

The Bamboo Works

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ArriVent BioPharma (AVBP) stock?

You can purchase shares of ArriVent BioPharma (NASDAQ: AVBP) through any online brokerage.

View our list of the best stock brokerages.

Who are ArriVent BioPharma's (AVBP) competitors?

Other companies in ArriVent BioPharma’s space includes: Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Altimmune (NASDAQ:ALT).

What is the target price for ArriVent BioPharma (AVBP) stock?

The latest price target for ArriVent BioPharma (NASDAQ: AVBP) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 25.00 expecting AVBP to rise to within 12 months (a possible 24.07% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for ArriVent BioPharma (AVBP)?

The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $20.15 last updated May 16, 2024 at 4:00 PM EDT.

Does ArriVent BioPharma (AVBP) pay a dividend?

There are no upcoming dividends for ArriVent BioPharma.

When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?

ArriVent BioPharma’s Q2 earnings are confirmed for Friday, August 2, 2024.

Is ArriVent BioPharma (AVBP) going to split?

There is no upcoming split for ArriVent BioPharma.

What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-